Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
•Demonstrate superior efficacy of tanezumab 5 mg and 2.5 mg administered subcutaneously (SC) every 8 weeks versus placebo at Week 24.
Inclusion criteria
- Osteoarthritis of the hip or knee